Tanaka Capital Management Inc / CN2
Tanaka Capital Management Inc’s Catalyst Pharmaceuticals Inc Position
Does Tanaka Capital Management Inc own Catalyst Pharmaceuticals Inc (CN2)? Yes — 113.4K shares worth $3M (+4.69% of its 13F portfolio) as of Q1 2026, down from 114.4K shares the prior filed quarter.
Position Value
$3M
Q1 2026
Shares
113.4K
% of Portfolio
+4.69%
Quarters Held
28
currently held
Position History CN2
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 113.4K | $3M | +4.69% |
| Q4 2025 | 114.4K | $3M | +4.87% |
| Q3 2025 | 114.4K | $2M | +4.06% |
| Q1 2025 | 151.9K | $4M | +8.77% |
| Q4 2024 | 153.3K | $3M | +7.31% |
| Q3 2024 | 153.3K | $3M | +7.05% |
| Q2 2024 | 153.4K | $2M | +5.62% |
| Q1 2024 | 153.4K | $2M | +6.02% |
| Q4 2023 | 154.4K | $3M | +6.35% |
| Q3 2023 | 159.8K | $2M | +5.34% |
| Q2 2023 | 159.8K | $2M | +5.81% |
| Q1 2023 | 148.3K | $2M | +7.14% |
| Q4 2022 | 148.3K | $3M | +8.75% |
| Q3 2022 | 148.3K | $2M | +5.68% |
| Q2 2022 | 197.3K | $1M | +4.50% |
| Q1 2022 | 208.2K | $2M | +3.49% |
| Q4 2021 | 213.6K | $1M | +2.75% |
| Q3 2021 | 203.1K | $1M | +1.53% |
| Q2 2021 | 173.1K | $995,000 | +1.34% |
| Q1 2021 | 224.8K | $1M | +1.31% |
| Q4 2020 | 225.3K | $752,000 | +1.67% |
| Q3 2020 | 252.2K | $749,000 | +2.35% |
| Q2 2020 | 283.5K | $1M | +4.06% |
| Q1 2020 | 277.8K | $1M | +4.68% |
| Q4 2019 | 282.4K | $1M | +3.36% |
| Q3 2019 | 283.3K | $2M | +4.86% |
| Q2 2019 | 225.6K | $866,000 | +2.65% |
| Q1 2019 | 233.8K | $1M | +3.59% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tanaka Capital Management Inc’s full portfolio or all institutional holders of CN2.